
|Articles|October 23, 2019
Monitoring of transdermal drug delivery in skin using the Renishaw Biological Analyser
Author(s)Renishaw, Inc.
Detecting the presence and depth of penetration of drug compounds in skin can prove challenging, current technologies fail to achieve adequate penetration through layers of dermal tissue. In this study, Raman spectroscopy using the Renishaw Biological Analyser - RA816 confirmed the presence of a topical compound in the epidermis and reticular dermis with high specificity and sensitivity.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
PharmTech Weekly News Roundup — Week of November 10, 2025
3
Share Your Perspective on the Commissioner’s National Priority Vouchers Program
4
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
5
